Diltiazem Hydrochloride Injection, Solution
Product Images NDC 55150-425

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 55150-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-25 mg Per 5 mL (5 mg/ml) (Container Label)

Package Label-principal Display Panel-25 mg Per 5 mL (5 mg/ml) (Container Label)
Diltiazem Hydrochloride Injection label showing 25 mg per 5 mL (5 mg/mL) strength in a 5 mL single-dose vial. The label specifies use for direct intravenous bolus injection and continuous intravenous infusion. It also notes that the product is sterile and manufactured in India for Eugia US LLC, with storage and discard instructions.*
FDA Label Image

Package Label-principal Display Panel-25 mg Per 5 mL (5 mg/ml) (Container-Carton)

Package Label-principal Display Panel-25 mg Per 5 mL (5 mg/ml) (Container-Carton)
Packaging label for Diltiazem HCl Injection, 25 mg per 5 mL (5 mg/mL) solution for intravenous use. The label includes instructions to discard unused portions and store under refrigeration. The product is supplied as 10 single-dose vials of 5 mL each and is distributed by Eugia US LLC. The label features a barcode and storage guidelines.*
FDA Label Image

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container Label)

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container Label)
Label for Diltiazem HCl Injection showing 5 mg/mL concentration in a 10 mL single-dose vial. Intended for direct intravenous bolus injection and continuous intravenous infusion. Manufactured in India for Eugia US LLC, Windsor, NJ. Includes NDC 55150-426-01 and instructions to see package insert for dosage.*
FDA Label Image

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container-Carton)

Package Label-principal Display Panel-50 mg Per 10 mL (5 mg/ml) (Container-Carton)
Packaging label for Diltiazem HCl Injection, 50 mg per 10 mL (5 mg/mL) intravenous injection solution. The label indicates it is for direct intravenous bolus injection and continuous intravenous infusion. The product is a sterile, single-dose vial format with 10 x 10 mL vials. Distributed by Eugia US LLC, the label includes storage instructions to store under refrigeration and discard unused portions.*
FDA Label Image

Package Label-principal Display Panel-125 mg Per 25 mL (5 mg/ml) (Container Label)

Package Label-principal Display Panel-125 mg Per 25 mL (5 mg/ml) (Container Label)
Label for Diltiazem HCl Injection 125 mg per 25 mL (5 mg/mL) solution for injection by Eugia US LLC. The product is a sterile 25 mL single-dose vial for direct intravenous bolus injection and continuous intravenous infusion. Storage instructions and warnings about single-dose use and temperature are included.*
FDA Label Image

Package Label-principal Display Panel-125 mg Per 25 mL (5 mg/ml) (Container-Carton)

Package Label-principal Display Panel-125 mg Per 25 mL (5 mg/ml) (Container-Carton)
Packaging label for Diltiazem HCl Injection 125 mg per 25 mL (5 mg/mL) intravenous solution by Eugia US LLC. The label indicates it is for direct intravenous bolus injection and continuous intravenous infusion, supplied as 10 single-dose 25 mL vials. Storage instructions specify refrigeration at 2° to 8°C (36° to 46°F) and discarding unused portion. Distributed by Eugia US LLC, made in India.*
FDA Label Image

Diltiazem-structure (Diltiazem Str)

Diltiazem-structure (Diltiazem Str)
Chemical structure diagram of diltiazem hydrochloride depicting its molecular framework with rings and functional groups, including a methoxy group and hydrochloride component, consistent with the active ingredient in DILTIAZEM HYDROCHLORIDE injection solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.